Breakthrough: First Drug Synthesized by AI Goes into Clinical Trials
An AI-Synthesized Drug Enters Clinical Trials For the First Time Ever
AI and Its Revolutionary Path Toward Drug Discovery
It feels like yesterday when computers first became integral in our lives; now, it is difficult to imagine existence without these fantastic machines. They are continuing to evolve in leaps and bounds, and soon, they will bring about more monumental change.
Envision a few decades from now: our children will be browsing our archives and marveling at how we struggled to make artificial intelligence a reality. They will learn about the day we had our very first encounter with the very first AI-synthesized drug. They will read about how excited we were when the drug went into clinical trials, how it fared, and perhaps, how it initiated a trend that would see AI identifying drug targets that could provide relief for several disease conditions worldwide.
If you are familiar with AI trends, you are likely cognizant of its vast possibilities. That it can surpass human intelligence and better apply information is something future generations will be grateful for. You may have heard that AI could hold the key to drug discovery, personalized and precision medicine…
